68 related articles for article (PubMed ID: 19330909)
1. Collagen antibody-induced arthritis in mice: development of a new arthritogenic 5-clone cocktail of monoclonal anti-type II collagen antibodies.
Hutamekalin P; Saito T; Yamaki K; Mizutani N; Brand DD; Waritani T; Terato K; Yoshino S
J Immunol Methods; 2009 Mar; 343(1):49-55. PubMed ID: 19330909
[TBL] [Abstract][Full Text] [Related]
2. Collagen epitope expression on B cells is sufficient to confer tolerance to collagen-induced arthritis.
Andersson SE; Eneljung T; Tengvall S; Jirholt P; Stern A; Henningsson L; Liang B; Thorarinsdottir K; Kihlberg J; Holmdahl R; Mårtensson IL; Gustafsson K; Gjertsson I
Arthritis Res Ther; 2016 Jun; 18(1):140. PubMed ID: 27301320
[TBL] [Abstract][Full Text] [Related]
3. Sialylation converts arthritogenic IgG into inhibitors of collagen-induced arthritis.
Ohmi Y; Ise W; Harazono A; Takakura D; Fukuyama H; Baba Y; Narazaki M; Shoda H; Takahashi N; Ohkawa Y; Ji S; Sugiyama F; Fujio K; Kumanogoh A; Yamamoto K; Kawasaki N; Kurosaki T; Takahashi Y; Furukawa K
Nat Commun; 2016 Apr; 7():11205. PubMed ID: 27046227
[TBL] [Abstract][Full Text] [Related]
4. Quaternary structure-dependent idiotope and antigen binding of a monoclonal antibody specific for conformational epitope on type II collagen.
Ito HO; Ueda T; Hashimoto Y; Imoto T; Koga T
Cell Mol Life Sci; 1997 Jan; 53(1):51-60. PubMed ID: 9117997
[TBL] [Abstract][Full Text] [Related]
5. Cartilage Oligomeric Matrix Protein Induced Arthritis-A New Model for Rheumatoid Arthritis in the C57BL/6 Mouse.
Zhao Y; Urbonaviciute V; Xu B; Cai W; Sener Z; Ge C; Holmdahl R
Front Immunol; 2021; 12():631249. PubMed ID: 33708221
[TBL] [Abstract][Full Text] [Related]
6. Fcgr2b and Fcgr3 are the major genetic factors for cartilage antibody-induced arthritis, overriding the effect of Hc encoding complement C5.
Xu Z; Moreno-Giró À; Zhao D; Krämer A; Pandey RK; Xu B; Lundström SL; Holmdahl R
Eur J Immunol; 2024 Apr; 54(4):e2350659. PubMed ID: 38314895
[TBL] [Abstract][Full Text] [Related]
7. [Animal models for bone and joint disease. CIA, CAIA model].
Hirose J; Tanaka S
Clin Calcium; 2011 Feb; 21(2):253-9. PubMed ID: 21289422
[TBL] [Abstract][Full Text] [Related]
8. A serine-conjugated butyrate prodrug with high oral bioavailability suppresses autoimmune arthritis and neuroinflammation in mice.
Cao S; Budina E; Raczy MM; Solanki A; Nguyen M; Beckman TN; Reda JW; Hultgren K; Ang PS; Slezak AJ; Hesser LA; Alpar AT; Refvik KC; Shores LS; Pillai I; Wallace RP; Dhar A; Watkins EA; Hubbell JA
Nat Biomed Eng; 2024 May; 8(5):611-627. PubMed ID: 38561491
[TBL] [Abstract][Full Text] [Related]
9.
Walther AR; Stepula E; Ditzel N; Kassem M; Bergholt MS; Hedegaard MAB
Anal Chem; 2023 Feb; 95(7):3720-3728. PubMed ID: 36757324
[TBL] [Abstract][Full Text] [Related]
10. Deciphering the pharmacological mechanisms of
Sun M; Zhao H; Liu Y; Ma Y; Tian Z; Wang H; Wei S; Guo Q; Gu Z; Jiang H
Food Sci Nutr; 2022 Oct; 10(10):3380-3394. PubMed ID: 36249962
[No Abstract] [Full Text] [Related]
11. MicroRNA-10b promotes arthritis development by disrupting CD4
Tu J; Han D; Fang Y; Jiang H; Tan X; Xu Z; Wang X; Hong W; Li T; Wei W
Mol Ther Nucleic Acids; 2022 Mar; 27():733-750. PubMed ID: 35317281
[TBL] [Abstract][Full Text] [Related]
12. Oral and Intestinal Bacterial Substances Associated with Disease Activities in Patients with Rheumatoid Arthritis: A Cross-Sectional Clinical Study.
Kitamura K; Shionoya H; Suzuki S; Fukai R; Uda S; Abe C; Takemori H; Nishimura K; Baba H; Katayama K; Terato K; Waritani T
J Immunol Res; 2022; 2022():6839356. PubMed ID: 35224112
[TBL] [Abstract][Full Text] [Related]
13. CD30-targeted therapy induces apoptosis of inflammatory cytokine-stimulated synovial fibroblasts and ameliorates collagen antibody-induced arthritis in mice.
Matsuhashi M; Nishida K; Sakamoto M; Gion Y; Yoshida A; Katsuyama T; Nakahara R; Nasu Y; Matsumoto Y; Sato Y; Ozaki T
Inflamm Res; 2022 Feb; 71(2):215-226. PubMed ID: 35064306
[TBL] [Abstract][Full Text] [Related]
14. HMGB1 released from nociceptors mediates inflammation.
Yang H; Zeng Q; Silverman HA; Gunasekaran M; George SJ; Devarajan A; Addorisio ME; Li J; Tsaava T; Shah V; Billiar TR; Wang H; Brines M; Andersson U; Pavlov VA; Chang EH; Chavan SS; Tracey KJ
Proc Natl Acad Sci U S A; 2021 Aug; 118(33):. PubMed ID: 34385304
[TBL] [Abstract][Full Text] [Related]
15. New Studies of Pathogenesis of Rheumatoid Arthritis with Collagen-Induced and Collagen Antibody-Induced Arthritis Models: New Insight Involving Bacteria Flora.
Hashida R; Shimozuru Y; Chang J; Agosto-Marlin I; Waritani T; Terato K
Autoimmune Dis; 2021; 2021():7385106. PubMed ID: 33833871
[TBL] [Abstract][Full Text] [Related]
16. Microbiota-derived butyrate limits the autoimmune response by promoting the differentiation of follicular regulatory T cells.
Takahashi D; Hoshina N; Kabumoto Y; Maeda Y; Suzuki A; Tanabe H; Isobe J; Yamada T; Muroi K; Yanagisawa Y; Nakamura A; Fujimura Y; Saeki A; Ueda M; Matsumoto R; Asaoka H; Clarke JM; Harada Y; Umemoto E; Komatsu N; Okada T; Takayanagi H; Takeda K; Tomura M; Hase K
EBioMedicine; 2020 Aug; 58():102913. PubMed ID: 32711255
[TBL] [Abstract][Full Text] [Related]
17. Cartilage-binding antibodies initiate joint inflammation and promote chronic erosive arthritis.
Li Y; Tong D; Liang P; Lönnblom E; Viljanen J; Xu B; Nandakumar KS; Holmdahl R
Arthritis Res Ther; 2020 May; 22(1):120. PubMed ID: 32448385
[TBL] [Abstract][Full Text] [Related]
18. Identification of a novel arthritis-associated osteoclast precursor macrophage regulated by FoxM1.
Hasegawa T; Kikuta J; Sudo T; Matsuura Y; Matsui T; Simmons S; Ebina K; Hirao M; Okuzaki D; Yoshida Y; Hirao A; Kalinichenko VV; Yamaoka K; Takeuchi T; Ishii M
Nat Immunol; 2019 Dec; 20(12):1631-1643. PubMed ID: 31740799
[TBL] [Abstract][Full Text] [Related]
19. β-Caryophyllene Mitigates Collagen Antibody Induced Arthritis (CAIA) in Mice Through a Cross-Talk between CB2 and PPAR-γ Receptors.
Irrera N; D'Ascola A; Pallio G; Bitto A; Mazzon E; Mannino F; Squadrito V; Arcoraci V; Minutoli L; Campo GM; Avenoso A; Bongiorno EB; Vaccaro M; Squadrito F; Altavilla D
Biomolecules; 2019 Jul; 9(8):. PubMed ID: 31370242
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Targeting Efficiency of Joints with Anticollagen II Antibodies.
Lofchy LA; Vu VP; Banda NK; Ramirez JR; Smith WJ; Gifford G; Gaikwad H; Scheinman RI; Simberg D
Mol Pharm; 2019 Jun; 16(6):2445-2451. PubMed ID: 31091104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
